Search Within

Genitourinary Oncology Service

  1. "2007"
Formats
  1. Journal Article (74)
  2. Meeting Abstract (54)
  3. Book Section (4)
  4. Book Whole (1)
  5. Conference Paper (1)
Groups
  1. Department of Medicine (134)
  2. Solid Tumor Oncology Division (134)
  3. GSK Faculty (32)
  4. Epidemiology and Biostatistics (27)
  5. Surgery (25)
  6. Biostatistics Service (23)

More Groups

People
  1. Robert Motzer (48)
  2. Howard Scher (36)
  3. David Solit (19)
  4. Dean Bajorin (17)
  5. Michael Morris (17)
  6. Gnanamba Kondagunta (12)

More People

Years
  1. 2007 (134)
Publications
  1. Journal of Clinical Oncology (37)
  2. Clinical Cancer Research (10)
  3. EJC Supplements (9)
  4. Journal of Urology (8)
  5. Cancer Research (6)
  6. Molecular Cancer Therapeutics (5)

More Publications

Publishers
  1. American Society of Clinical Oncology (37)
  2. American Association for Cancer Research (21)
  3. Elsevier Science, Inc. (14)
  4. Pergamon-Elsevier Science Ltd (9)
  5. Springer (7)
  6. Nature Publishing Group (5)

More Publishers

Results (134)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The Prostate Cancer Clinical Trials Working Group (PCCTWG) consensus criteria for phase II clinical trials for castration-resistant prostate cancer
    Meeting Abstract

    Scher, H. I.; Halabi, S.; Tannock, I.; Morris, M.; Higano, C.; Kelly, W.; Sternberg, C.; Eisenberger, M.; Martin, A.; Hussain, M.; more...
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Sunitinib therapy for patients (pts) with metastatic renal cell carcinoma (mRCC): Updated results of two phase II trials and prognostic factor analysis for survival
    Meeting Abstract

    Rosenberg, J. E.; Motzer, R. J.; Michaelson, M. D.; Redman, B. G.; Hudes, G. R.; Bukowski, R. M.; George, D. J.; Kim, S. T.; Baum, C. M.; Wilding, G.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Phase I/II study of sunitinib malate in combination with gefitinib in patients (pts) with metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    Patel, P. H.; Kondagunta, G. V.; Redman, B. G.; Hudes, G. R.; Kim, S. T.; Chen, I.; Motzer, R. J.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • BRAF mutation predicts MEK-dependence in non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Pratilas, C. A.; Halilovic, E.; Sawai, A.; Grbovic-Huezo, O.; Rosen, N.; Solit, D. B.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • A phase II trial of rapid androgen cycling and docetaxel (Doc) in prostate cancer patients with a rising prostate-specific antigen (PSA) in the noncastrate state
    Meeting Abstract

    Rathkopf, D. E.; Carducci, M. A.; Slovin, S.; Morris, M. J.; Kelsen, M.; Pili, R.; Denmeade, S. R.; Eisenberger, M.; Scher, H. I.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Phase I study of docetaxel and (153)Sm repetitively administered for castrate metastatic prostate cancer (CMPC)
    Meeting Abstract

    Morris, M. J.; Pandit-Taskar, N.; Amodio, A. J.; Gignac, G. A.; Flatts, E.; Slovin, S.; Solit, D.; Rathkopf, D.; Larson, S.; Scher, H. I.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Sunitinib versus interferon-alfa (IFN-α) as first-line treatment of metastatic renal cell carcinoma (mRCC): Updated results and analysis of prognostic factors
    Meeting Abstract

    Motzer, R. J.; Figlin, R. A.; Hutson, T. E.; Tomczak, P.; Bukowski, R. M.; Rixe, O.; Bjarnason, G. A.; Kim, S. T.; Chen, I.; Michaelson, D.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • A retropective analysis of colorectal cancer in adolescents and young adults: A report from the Surgical Committee of the Children's Oncology Group
    Meeting Abstract

    La Quaglia, M. P.; Morris, M.; Shia, J.; Idrees, K.; Rosenberg, S.; Ishill, N.; Shamberger, R. C.; Doski, J. J.; Heller, G.; Paty, P. B.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Sunitinib malate (SU) plus interferon (IFN) in first line metastatic renal cell cancer (mRCC): Results of a dose-finding study
    Meeting Abstract

    Kondagunta, G. V.; Hudes, G. R.; Figlin, R.; Wilding, G.; Hariharan, S.; Kempin, S. N.; Fayyad, R.; Hoosen, S.; Motzer, R. J.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Different chromosomal alterations correlate with gene expression in African American (AA) versus Caucasian American (CA) prostate cancer (PC) patients
    Meeting Abstract

    Jean-Gilles, J. Jr; Satagopan, J.; Zhou, Q.; Dash, A.; Yu, J.; Lee, P.; Scher, H. I.; Gerald, W.; Osman, I.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save